HopeStage
Back to overview

Depression studies

Topics
More filters

Depression

Depression involves persistent low mood or loss of interest, often with tiredness and changes in sleep or appetite.

7264studies shown
Showing 2,857-2,868 of 7,264
Behavioral study icon
CompletedACTRN12620001372976

A feasibility study assessing the effect of an active virtual reality gaming intervention on physical activity and mood in young men with mild to moderate depression.

Official study title

A randomised feasibility study assessing the effect of an active virtual reality gaming intervention on physical activity and mood in young men with mild to moderate depression as compared to a wait list control.

This study has finished and is no longer accepting participants.

In Australia
DepressionInterventional studyAges 18–29
Countries
Australia
Sponsor
Western Sydney University
Behavioral study icon
TerminatedACTRN12622000777796

Adjunct herbal medicine formulation for depression

Official study title

A randomised placebo-controlled trial examining the efficacy and safety of an adjunct herbal medicine formulation in patients with major depressive disorder and poor response to anti-depressant therapy

This study ended early.

In Australia
Depression, AnxietyInterventional studyAges 18–65
Countries
Australia
Sponsor
Integria Healthcare (Australia) Pty. Ltd.
Behavioral study icon
WithdrawnACTRN12614000756628

A controlled study of a novel visualisation technique to improve emotional control in people with depression in primary care.

Official study title

Patients with depression in primary care with a PHQ-9 score between 10 and 20 will be given a novel visualisation technique and advised to exercise regularly and given sleep hygiene advice versus advised to exercise regularly and given sleep hygiene advice with the outcome at 8 weeks of a PHQ-9 score <7 or a score of < 6 on the self reported Montgomery-Asberg scale.

This study was withdrawn before enrollment.

In New Zealand
DepressionInterventional studyAges 16–75
Countries
New Zealand
Sponsor
University of Auckland
Drug study icon
CompletedACTRN12616001351404

Safety study of ketamine in depression

Official study title

A single centre, double blind, randomised , parallel group, ascending single and multiple dose, safety and tolerability, pharmacokinetic and pharmacodynamic study of oral ketamine in healthy volunteer and patients with a history of depression or anxiety cohorts.

This study has finished and is no longer accepting participants.

In New Zealand
Depression, AnxietyInterventional studyAges 18–60
Countries
New Zealand
Sponsor
Zenith Technology Corp Ltd
Drug study icon
WithdrawnACTRN12617001130358

Ketamine in Elderly people with Depression.

Official study title

Pilot study evaluating the efficacy of subcutaneous ketamine for the treatment of depression in the elderly.

This study was withdrawn before enrollment.

In New Zealand
DepressionInterventional studyAges 65+
Countries
New Zealand
Sponsor
University of Otago

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.